Expression of noncoding vault RNA in human malignant cells and its importance in mitoxantrone resistance

Subash C B Gopinath1, Renu Wadhwa, Penmetcha K R Kumar

  • 1RNA Processing Group, Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology, Central 6, 1-1-1 Higashi, Tsukuba City 305-8566, Ibaraki, Japan.

Insights

Vault RNA (vRNA) overexpression correlates with increased resistance to the chemotherapy drug mitoxantrone in cancer cells. Suppressing vRNA expression reduced this resistance, suggesting vRNA

Area of Science:

  • Molecular Biology
  • Cancer Research
  • RNA Biology

Background:

  • Noncoding RNAs (ncRNAs) play crucial roles in cellular functions like gene regulation.
  • Vault RNA (vRNA) has previously demonstrated the ability to recognize chemotherapeutic compounds.
  • Understanding ncRNA roles in drug resistance is vital for cancer treatment.

Purpose of the Study:

  • To investigate the role of vault RNA (vRNA) in the resistance of cancer cells to mitoxantrone.
  • To determine if vRNA expression levels correlate with mitoxantrone resistance in malignant cell lines.

Main Methods:

  • Analysis of vRNA expression levels in human glioblastoma, leukemia, and osteosarcoma cell lines.
  • RNA interference (RNAi) was used to suppress vRNA expression.
  • Assessing the impact of vRNA suppression and overexpression on mitoxantrone resistance.

Main Results:

  • Human glioblastoma, leukemia, and osteosarcoma cell lines overexpress vRNA.
  • These cell lines exhibit increased resistance to mitoxantrone.
  • Suppression of vRNA expression led to a decrease in mitoxantrone resistance.
  • Overexpression of vRNA-1 specifically conferred resistance to mitoxantrone.

Conclusions:

  • Vault RNA (vRNA) plays a significant role in mediating mitoxantrone resistance in malignant cells.
  • These findings highlight the potential of targeting vRNA in cancer chemotherapeutics.
  • Further research is warranted to explore the therapeutic applications of ncRNAs in cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...